UBS Group’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $61M | Buy |
594,170
+332,250
| +127% | +$37.5M | 0.01% | 1442 |
|
|
2025
Q4 | $32.8M | Sell |
261,920
-25,357
| -9% | -$3.23M | 0.01% | 2075 |
|
|
2025
Q3 | $38.5M | Sell |
287,277
-11,500
| -4% | -$1.51M | 0.01% | 1893 |
|
|
2025
Q2 | $40.6M | Sell |
298,777
-45,600
| -13% | -$6.01M | 0.01% | 1707 |
|
|
2025
Q1 | $45.7M | Sell |
344,377
-349,100
| -50% | -$44.4M | 0.01% | 1558 |
|
|
2024
Q4 | $78.4M | Sell |
693,477
-201,100
| -22% | -$23.2M | 0.01% | 1077 |
|
|
2024
Q3 | $102M | Buy |
894,577
+342,300
| +62% | +$37.5M | 0.02% | 706 |
|
|
2024
Q2 | $57.4M | Buy |
552,277
+26,620
| +5% | +$2.82M | 0.01% | 947 |
|
|
2024
Q1 | $59.7M | Sell |
525,657
-13,753
| -3% | -$1.58M | 0.01% | 927 |
|
|
2023
Q4 | $59.4M | Buy |
539,410
+339,510
| +170% | +$33.9M | 0.02% | 878 |
|
|
2023
Q3 | $19.4M | Sell |
199,900
-57,900
| -22% | -$6.08M | 0.01% | 1503 |
|
|
2023
Q2 | $28.1M | Buy |
257,800
+122,000
| +90% | +$13M | 0.01% | 1192 |
|
|
2023
Q1 | $13.8M | Buy |
135,800
+45,200
| +50% | +$4.77M | 0.01% | 1664 |
|
|
2022
Q4 | $9.95M | Sell |
90,600
-118,600
| -57% | -$12.3M | ﹤0.01% | 1936 |
|
|
2022
Q3 | $20.2M | Buy |
+209,200
| New | +$22.3M | 0.01% | 1266 |
|
|
2022
Q2 | – | Sell |
-32,200
| Closed | -$3.81M | – | 10230 |
|
|
2022
Q1 | $3.81M | Sell |
32,200
-182,600
| -85% | -$22.6M | ﹤0.01% | 2808 |
|
|
2021
Q4 | $30.2M | Buy |
214,800
+103,667
| +93% | +$13.3M | 0.01% | 1285 |
|
|
2021
Q3 | $13.1M | Hold |
111,133
| – | – | ﹤0.01% | 1839 |
|
|
2021
Q2 | $12.9M | Sell |
111,133
-4,000
| -3% | -$466K | ﹤0.01% | 1828 |
|
|
2021
Q1 | $13.8M | Buy |
115,133
+24,033
| +26% | +$2.85M | ﹤0.01% | 1689 |
|
|
2020
Q4 | $9.97M | Buy |
91,100
+56,700
| +165% | +$6.16M | ﹤0.01% | 1846 |
|
|
2020
Q3 | $3.74M | Sell |
34,400
-20,000
| -37% | -$2.03M | ﹤0.01% | 2469 |
|
|
2020
Q2 | $4.97M | Sell |
54,400
-20,600
| -27% | -$1.86M | ﹤0.01% | 2055 |
|
|
2020
Q1 | $5.92M | Sell |
75,000
-110,400
| -60% | -$9.21M | ﹤0.01% | 1787 |
|
|
2019
Q4 | $16.1M | Buy |
185,400
+45,400
| +32% | +$3.8M | 0.01% | 1529 |
|
|
2019
Q3 | $11.7M | Buy |
140,000
+90,000
| +180% | +$7.65M | ﹤0.01% | 1643 |
|
|
2019
Q2 | $4.21M | Hold |
50,000
| – | – | ﹤0.01% | 2473 |
|
|
2019
Q1 | $4M | Buy |
+50,000
| New | +$3.72M | ﹤0.01% | 2390 |
|
|
2018
Q4 | – | Sell |
-27,300
| Closed | -$2M | – | 7984 |
|
|
2018
Q3 | $2M | Buy |
+27,300
| New | +$1.79M | ﹤0.01% | 3223 |
|
|
2018
Q2 | – | Sell |
-40,500
| Closed | -$2.43M | – | 7935 |
|
|
2018
Q1 | $2.43M | Buy |
40,500
+22,900
| +130% | +$1.38M | ﹤0.01% | 2972 |
|
|
2017
Q4 | $1M | Buy |
+17,600
| New | +$975K | ﹤0.01% | 3783 |
|
|
2016
Q3 | – | Sell |
-26,700
| Closed | -$1.05M | – | 7633 |
|
|
2016
Q2 | $1.05M | Buy |
+26,700
| New | +$1.06M | ﹤0.01% | 3337 |
|
|
2016
Q1 | – | Sell |
-44,200
| Closed | -$1.99M | – | 7573 |
|
|
2015
Q4 | $1.99M | Buy |
44,200
+37,100
| +523% | +$1.64M | ﹤0.01% | 2797 |
|
|
2015
Q3 | $286K | Sell |
7,100
-3,100
| -30% | -$146K | ﹤0.01% | 4354 |
|
|
2015
Q2 | $501K | Sell |
10,200
-6,700
| -40% | -$322K | ﹤0.01% | 4121 |
|
|
2015
Q1 | $783K | Sell |
16,900
-32,400
| -66% | -$1.49M | ﹤0.01% | 3787 |
|
|
2014
Q4 | $2.22M | Buy |
+49,300
| New | +$2.15M | ﹤0.01% | 2806 |
|
Other funds holding ABT
VCM
VPM
UBS Group's ABT Position: Q1 2026 in Review
UBS Group increased its Abbott (ABT) stake by 16% in Q1 2026, buying an estimated $189M and bringing the position to 12,152,765 shares worth $1.25B. The position accounts for 0.19% of the portfolio, ranked #99.
UBS Group first reported a position in ABT in Q4 2014 and has held it in 46 quarters since. The position peaked at $1.31B in Q3 2025. 3,086 funds tracked by Wall St. Rank hold ABT as of Q1 2026.
- UBS Group held 12,152,765 shares of Abbott worth $1.25B as of Q1 2026.
- UBS Group bought 1,672,696 Abbott shares in Q1 2026, an estimated $189M.
- Abbott made up 0.19% of UBS Group's portfolio in Q1 2026, its #99 holding.
- UBS Group first reported a position in Abbott in Q4 2014 and has held it in 46 quarters since.
- UBS Group's Abbott position peaked at $1.31B in Q3 2025.
- 3,086 funds tracked by Wall St. Rank held Abbott as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.